These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10629009)

  • 1. In vitro activity of fusidic acid against streptococci isolated from skin and soft tissue infections.
    Leclercq R; Bismuth R; Casin I; Cavallo JD; Croizé J; Felten A; Goldstein F; Monteil H; Quentin-Noury C; Reverdy M; Vergnaud M; Roiron R
    J Antimicrob Chemother; 2000 Jan; 45(1):27-9. PubMed ID: 10629009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
    Afset JE; Maeland JA
    Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
    Akiyama H; Yamasaki O; Kanzaki H; Tada J; Arata J
    J Dermatol Sci; 1999 Jan; 19(1):17-22. PubMed ID: 9890370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusidic acid in skin and soft tissue infections.
    Spelman D
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S59-66. PubMed ID: 10528787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
    Pfaller MA; Castanheira M; Sader HS; Jones RN
    Int J Antimicrob Agents; 2010 Mar; 35(3):282-7. PubMed ID: 20036520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
    Loeffler A; Baines SJ; Toleman MS; Felmingham D; Milsom SK; Edwards EA; Lloyd DH
    J Antimicrob Chemother; 2008 Dec; 62(6):1301-4. PubMed ID: 18819974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
    Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Int J Antimicrob Agents; 2013 Apr; 41(4):337-42. PubMed ID: 23466338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.
    Clark SM; Loeffler A; Bond R
    J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tentative interpretative zone diameters for fusidic acid Neosensitabs on Mueller Hinton agar and three blood containing media.
    Skov R; Frimodt-Møller N; Espersen F
    Int J Antimicrob Agents; 2003 Nov; 22(5):502-7. PubMed ID: 14602369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections.
    Pfaller MA; Rhomberg PR; Sader HS; Mendes RE; Jones RN
    J Chemother; 2010 Oct; 22(5):304-11. PubMed ID: 21123152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
    Biedenbach DJ; Arhin FF; Moeck G; Lynch TF; Sahm DF
    Int J Antimicrob Agents; 2015 Dec; 46(6):674-81. PubMed ID: 26541881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The postantibiotic effect of fusidic acid against gram-positive bacteria.
    Munckhof WJ; Turnidge JD
    J Antimicrob Chemother; 1997 Sep; 40(3):433-6. PubMed ID: 9338499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).
    Mendes RE; Farrell DJ; Sader HS; Flamm RK; Jones RN
    J Antimicrob Chemother; 2015 Feb; 70(2):498-504. PubMed ID: 25362568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug sensitivity of bacterial strains isolated from clinical specimens during the years 1987-1988].
    Rafałowska K; Leszczyński P
    Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):732-5. PubMed ID: 2084629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusidic acid in vitro activity.
    Collignon P; Turnidge J
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S45-58. PubMed ID: 10528786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102).
    Biedenbach DJ; Rhomberg PR; Mendes RE; Jones RN
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):301-7. PubMed ID: 20159376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.